Related references
Note: Only part of the references are listed.The candidate tuberculosis vaccine Mtb72F/AS02 in PPD positive adults: A randomized controlled phase I/II study
Francois Spertini et al.
TUBERCULOSIS (2013)
Improved CD4(+) T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: A randomized trial
Isabel Leroux-Roels et al.
VACCINE (2013)
A Phase IIa Trial of the New Tuberculosis Vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected Adults
Thomas J. Scriba et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
The Importance of Adjuvant Formulation in the Development of a Tuberculosis Vaccine
Susan L. Baldwin et al.
JOURNAL OF IMMUNOLOGY (2012)
Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go?
Tom H. M. Ottenhoff et al.
PLOS PATHOGENS (2012)
Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
Nathalie Garcon et al.
EXPERT REVIEW OF VACCINES (2011)
H5N1 Influenza Vaccine Formulated with AS03A Induces Strong Cross-Reactive and Polyfunctional CD4 T-Cell Responses
Philippe Moris et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
Dose-Finding Study of the Novel Tuberculosis Vaccine, MVA85A, in Healthy BCG-Vaccinated Infants
Thomas J. Scriba et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
A multistage tuberculosis vaccine that confers efficient protection before and after exposure
Claus Aagaard et al.
NATURE MEDICINE (2011)
BCG sub-strains induce variable protection against virulent pulmonary Mycobacterium tuberculosis infection, with the capacity to drive Th2 immunity
Andrew Keyser et al.
VACCINE (2011)
The Novel Tuberculosis Vaccine, AERAS-402, Induces Robust and Polyfunctional CD4+ and CD8+ T Cells in Adults
Brian Abel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Specific T Cell Frequency and Cytokine Expression Profile Do Not Correlate with Protection against Tuberculosis after Bacillus Calmette-Guerin Vaccination of Newborns
Benjamin M. N. Kagina et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Evaluation of the Safety and Immunogenicity of Two Antigen Concentrations of the Mtb72F/AS02A Candidate Tuberculosis Vaccine in Purified Protein Derivative-Negative Adults
Isabel Leroux-Roels et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
The quest for biomarkers in tuberculosis
Shreemanta K. Parida et al.
DRUG DISCOVERY TODAY (2010)
Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4(+) T cells
Thomas J. Scriba et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Multifunctional CD4+ T cells correlate with active Mycobacterium tuberculosis infection
Nadia Caccamo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Expanded Polyfunctional T Cell Response to Mycobacterial Antigens in TB Disease and Contraction Post-Treatment
James M. Young et al.
PLOS ONE (2010)
A Longitudinal Study of BCG Vaccination in Early Childhood: The Development of Innate and Adaptive Immune Responses
Yenny Djuardi et al.
PLOS ONE (2010)
Complex cytokine profiles induced by BCG vaccination in UK infants
Maeve K. Lalor et al.
VACCINE (2010)
Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Mycobacterium tuberculosis-infected Individuals
Clare R. Sander et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
The protective role of antibody responses during Mycobacterium tuberculosis infection
F. Abebe et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
The candidate tuberculosis vaccine Mtb72F/AS02A Tolerability and immunogenicity in humans
Kenneth Von Eschen et al.
HUMAN VACCINES (2009)
Quality and Vaccine Efficacy of CD4+ T Cell Responses Directed to Dominant and Subdominant Epitopes in ESAT-6 from Mycobacterium tuberculosis
Claus Sindbjerg Aagaard et al.
JOURNAL OF IMMUNOLOGY (2009)
Tuberculosis Subunit Vaccination Provides Long-Term Protective Immunity Characterized by Multifunctional CD4 Memory T Cells
Thomas Lindenstrom et al.
JOURNAL OF IMMUNOLOGY (2009)
Distinct Differences in the Expansion and Phenotype of TB10.4 Specific CD8 and CD4 T Cells after Infection with Mycobacterium tuberculosis
Truc Thi Kim Thanh Hoang et al.
PLOS ONE (2009)
Protection and Polyfunctional T Cells Induced by Ag85B-TB10.4/IC31® against Mycobacterium tuberculosis Is Highly Dependent on the Antigen Dose
Claus Aagaard et al.
PLOS ONE (2009)
Persistence of the immune response induced by BCG vaccination
Rosemary E. Weir et al.
BMC INFECTIOUS DISEASES (2008)
Mycobacterium tuberculosis-specific CD4+, IFNγ+, and TNFα+ multifunctional memory T cells coexpress GM-CSF
Henrik Mueller et al.
CYTOKINE (2008)
Standardization and Optimization of Multiparameter Intracellular Cytokine Staining
Laurel Nomura et al.
CYTOMETRY PART A (2008)
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa
Tony Hawkridge et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Natural Variation in Immune Responses to Neonatal Mycobacterium bovis Bacillus Calmette-Guerin (BCG) Vaccination in a Cohort of Gambian Infants
Chris Finan et al.
PLOS ONE (2008)
Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations
Natalie E. R. Beveridge et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
GlaxoSmithKline Adjuvant systems in vaccines: concepts, achievements and perspectives
Nathalie Garcon et al.
EXPERT REVIEW OF VACCINES (2007)
Immune systems in developed and developing countries; implications for the design of vaccines that will work where BCG does not
Graham A. W. Rook et al.
TUBERCULOSIS (2006)
Effect of BCG vaccination on childhood tuberculous meningitis and miliarytuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness
BB Trunz et al.
LANCET (2006)
Immunological control of tuberculosis: Role of tumour necrosis factor and more
S Stenger
ANNALS OF THE RHEUMATIC DISEASES (2005)
Direct access to CD4+ T cells specific for defined antigens according to CD154 expression
M Frentsch et al.
NATURE MEDICINE (2005)
A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles
PK Chattopadhyay et al.
NATURE MEDICINE (2005)
Immune responses to tuberculosis in developing countries: implications for new vaccines
GAW Rook et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting?
GAW Rook et al.
VACCINE (2005)
Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein
YAW Skeiky et al.
JOURNAL OF IMMUNOLOGY (2004)
Immunology of tuberculosis and implications in vaccine development
JL Flynn
TUBERCULOSIS (2004)
Duration of antiviral immunity after smallpox vaccination
E Hammarlund et al.
NATURE MEDICINE (2003)
Current medical treatment for tuberculosis
ED Chan et al.
BMJ-BRITISH MEDICAL JOURNAL (2002)
The heparin-binding haemagglutinin of M-tuberculosis is required for extrapulmonary dissemination
K Pethe et al.
NATURE (2001)
Interleukin 4 and 13 participation in mycobacterial (type-1) and schistosomal (type-2) antigen-elicited pulmonary granuloma formation: Multiparameter analysis of cellular recruitment, chemokine expression and cytokine networks
JH Ruth et al.
CYTOKINE (2000)
Share Paper
